CEO Letters



Happy Summer, Virginia Bio! It’s been a very busy summer here at Virginia Bio, and we know you have been busy as well!  We see you out there on social media and other communication vehicles,and we were thrilled to have seen many of you “live and in person” at events and socials across the state. 


December 2022 – Happy Holidays Virginia Bio!

Join us at the Virginia Reception at the JP Morgan Healthcare Conference on January 8, 2023! The New Year is nearly here! Your Virginia Bio team wants to THANK YOU for allowing us to partner with you and support all the wonderful things you are doing for our life sciences ecosystem in the Commonwealth and beyond! It has


July 2022

Message from the Chairman of the Virginia Bioscience Foundation, Jim Powers – Virginia Bioscience Foundation Announces Funding of Summer STEM Camps for Minority and Underserved Students –   The Virginia Bioscience Foundation announces three summer science programs that have been awarded through the Jeffrey Gallagher Scholarship Fund to encourage interest in life science studies among


May 2022

Message from Departing Chairman Dear Virginia Bio friends: It was great to see many of you in person last month at the THRiVE 2022 conference. As you know, my time as Virginia Bio Association Chairman has come to an end, and John offered me the opportunity to share a few thoughts about my time with


April 2022

Members and Friends, Despite confinement and exclusively virtual communication with colleagues, investors, and customers for the better part of two years, our Virginia life sciences eco-system has had a productive run. We’ve assisted in the global fight against the pandemic, we’ve innovated and developed new technologies, drugs, and treatments, and we’ve continued to build our


March 2022

Members and Friends, For the first time, Virginia’s life science organizations will have a central location for its resources, jobs, and events. With the launch of the web portal Virginia Bio-Connect (, individuals from across the country and the world will be able to obtain a broader picture of the life sciences assets that the